296 related articles for article (PubMed ID: 29685397)
1. Outcomes of Outpatient Parenteral Antimicrobial Therapy in Patients With Injection Drug Use.
Vazirian M; Jerry JM; Shrestha NK; Gordon SM
Psychosomatics; 2018; 59(5):490-495. PubMed ID: 29685397
[TBL] [Abstract][Full Text] [Related]
2. Self-Administered Outpatient Antimicrobial Infusion by Uninsured Patients Discharged from a Safety-Net Hospital: A Propensity-Score-Balanced Retrospective Cohort Study.
Bhavan KP; Brown LS; Haley RW
PLoS Med; 2015 Dec; 12(12):e1001922. PubMed ID: 26671467
[TBL] [Abstract][Full Text] [Related]
3. Association of laboratory test result availability and rehospitalizations in an outpatient parenteral antimicrobial therapy programme.
Huck D; Ginsberg JP; Gordon SM; Nowacki AS; Rehm SJ; Shrestha NK
J Antimicrob Chemother; 2014 Jan; 69(1):228-33. PubMed ID: 23887864
[TBL] [Abstract][Full Text] [Related]
4. Successful implementation of outpatient parenteral antimicrobial therapy at a medical respite facility for homeless patients.
Beieler AM; Dellit TH; Chan JD; Dhanireddy S; Enzian LK; Stone TJ; Dwyer-O'Connor E; Lynch JB
J Hosp Med; 2016 Aug; 11(8):531-5. PubMed ID: 27120700
[TBL] [Abstract][Full Text] [Related]
5. Adverse events, healthcare interventions and healthcare utilization during home infusion therapy with daptomycin and vancomycin: a propensity score-matched cohort study.
Shrestha NK; Mason P; Gordon SM; Neuner E; Nutter B; O'Rourke C; Rehm SJ
J Antimicrob Chemother; 2014 May; 69(5):1407-15. PubMed ID: 24398341
[TBL] [Abstract][Full Text] [Related]
6. The use, appropriateness and outcomes of outpatient parenteral antimicrobial therapy.
Hodgson KA; Huynh J; Ibrahim LF; Sacks B; Golshevsky D; Layley M; Spagnolo M; Raymundo CM; Bryant PA
Arch Dis Child; 2016 Oct; 101(10):886-93. PubMed ID: 27166221
[TBL] [Abstract][Full Text] [Related]
7. Simulated Cost-effectiveness and Long-term Clinical Outcomes of Addiction Care and Antibiotic Therapy Strategies for Patients With Injection Drug Use-Associated Infective Endocarditis.
Adams JW; Savinkina A; Hudspeth JC; Gai MJ; Jawa R; Marks LR; Linas BP; Hill A; Flood J; Kimmel S; Barocas JA
JAMA Netw Open; 2022 Feb; 5(2):e220541. PubMed ID: 35226078
[TBL] [Abstract][Full Text] [Related]
8. Outcomes of patients with a history of injecting drug use and receipt of outpatient antimicrobial therapy.
O'Callaghan K; Tapp S; Hajkowicz K; Legg A; McCarthy KL
Eur J Clin Microbiol Infect Dis; 2019 Mar; 38(3):575-580. PubMed ID: 30680563
[TBL] [Abstract][Full Text] [Related]
9. Safety and effectiveness of outpatient parenteral antimicrobial therapy in older people.
Mujal A; Sola J; Hernandez M; Villarino MA; Baylina M; Tajan J; Oristrell J
J Antimicrob Chemother; 2016 May; 71(5):1402-7. PubMed ID: 26832749
[TBL] [Abstract][Full Text] [Related]
10. Mandatory infectious diseases approval of outpatient parenteral antimicrobial therapy (OPAT): clinical and economic outcomes of averted cases.
Conant MM; Erdman SM; Osterholzer D
J Antimicrob Chemother; 2014 Jun; 69(6):1695-700. PubMed ID: 24532684
[TBL] [Abstract][Full Text] [Related]
11. Outpatient parenteral antimicrobial therapy (OPAT) in Christchurch: 18 years on.
Chambers ST; Basevi A; Gallagher K; Carswell-Moyna A; Isenman H; Pithie A; Dalton S; Metcalf SC
N Z Med J; 2019 Aug; 132(1501):21-32. PubMed ID: 31465324
[TBL] [Abstract][Full Text] [Related]
12. Setting up an outpatient parenteral antimicrobial therapy (OPAT) unit in Switzerland: review of the first 18 months of activity.
Gardiol C; Voumard R; Cochet C; de Vallière S
Eur J Clin Microbiol Infect Dis; 2016 May; 35(5):839-45. PubMed ID: 26886452
[TBL] [Abstract][Full Text] [Related]
13. Cost-utility analysis of outpatient parenteral antimicrobial therapy (OPAT) in the Brazilian national health system.
Psaltikidis EM; Silva END; Moretti ML; Trabasso P; Stucchi RSB; Aoki FH; Cardoso LGO; Höfling CC; Bachur LF; Ponchet DDF; Colombrini MRC; Tozzi CS; Ramos RF; Costa SMQ; Resende MR
Expert Rev Pharmacoecon Outcomes Res; 2019 Jun; 19(3):341-352. PubMed ID: 30362845
[TBL] [Abstract][Full Text] [Related]
14. Vascular access complications during outpatient parenteral antimicrobial therapy at home: a retrospective cohort study.
Shrestha NK; Shrestha J; Everett A; Carroll D; Gordon SM; Butler RS; Rehm SJ
J Antimicrob Chemother; 2016 Feb; 71(2):506-12. PubMed ID: 26510718
[TBL] [Abstract][Full Text] [Related]
15. Risk of venous thromboembolism in patients treated for bacterial infection in the community with outpatient parenteral antimicrobial therapy.
Barr DA; Irvine S; Ritchie ND; McCutcheon J; Seaton RA
QJM; 2014 Mar; 107(3):207-11. PubMed ID: 24300160
[TBL] [Abstract][Full Text] [Related]
16. Selecting antibacterials for outpatient parenteral antimicrobial therapy : pharmacokinetic-pharmacodynamic considerations.
Slavik RS; Jewesson PJ
Clin Pharmacokinet; 2003; 42(9):793-817. PubMed ID: 12882587
[TBL] [Abstract][Full Text] [Related]
17. Outpatient Versus Inpatient Intravenous Antimicrobial Therapy: A Population-Based Observational Cohort Study of Adverse Events and Costs.
Staples JA; Ho M; Ferris D; Hayek J; Liu G; Tran KC; Sutherland JM
Clin Infect Dis; 2022 Nov; 75(11):1921-1929. PubMed ID: 35439822
[TBL] [Abstract][Full Text] [Related]
18. Outcomes from global adult outpatient parenteral antimicrobial therapy programmes: a review of the last decade.
MacKenzie M; Rae N; Nathwani D
Int J Antimicrob Agents; 2014 Jan; 43(1):7-16. PubMed ID: 24200469
[TBL] [Abstract][Full Text] [Related]
19. Characteristics and outcomes of outpatient parenteral antimicrobial therapy at an academic children's hospital.
Madigan T; Banerjee R
Pediatr Infect Dis J; 2013 Apr; 32(4):346-9. PubMed ID: 23249915
[TBL] [Abstract][Full Text] [Related]
20. Outpatient parenteral antimicrobial therapy at large Veterans Administration medical center.
Lai A; Tran T; Nguyen HM; Fleischmann J; Beenhouwer DO; Graber CJ
Am J Manag Care; 2013 Sep; 19(9):e317-24. PubMed ID: 24449959
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
